I don’t disagree… What I meant was he is prioritizing on foreign agencies… My point is the company‘s position does not grow stronger over time it grows weaker and therefore I would like them to turn their cards over on the table as soon as possible... I think they are much better off going after foreign agency‘s first because there will be no US FDA negative response to combat so why not give others the first crack at it as soon as possible?